144 related articles for article (PubMed ID: 29225473)
1. The combination therapy of salinomycin and gefitinib using poly(d,l-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles for targeting both lung cancer stem cells and cancer cells.
Zhang Y; Zhang Q; Sun J; Liu H; Li Q
Onco Targets Ther; 2017; 10():5653-5666. PubMed ID: 29225473
[TBL] [Abstract][Full Text] [Related]
2. Codelivery of salinomycin and docetaxel using poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles to target both gastric cancer cells and cancer stem cells.
Li L; Cui D; Ye L; Li Y; Zhu L; Yang L; Bai B; Nie Z; Gao J; Cao Y
Anticancer Drugs; 2017 Oct; 28(9):989-1001. PubMed ID: 28692437
[TBL] [Abstract][Full Text] [Related]
3. The enhanced delivery of salinomycin to CD133
Mi Y; Huang Y; Deng J
Oncol Lett; 2018 May; 15(5):6611-6621. PubMed ID: 29725407
[TBL] [Abstract][Full Text] [Related]
4. Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells.
Ni M; Xiong M; Zhang X; Cai G; Chen H; Zeng Q; Yu Z
Int J Nanomedicine; 2015; 10():2537-54. PubMed ID: 25848270
[TBL] [Abstract][Full Text] [Related]
5. Salinomycin-loaded lipid-polymer nanoparticles with anti-CD20 aptamers selectively suppress human CD20+ melanoma stem cells.
Zeng YB; Yu ZC; He YN; Zhang T; Du LB; Dong YM; Chen HW; Zhang YY; Wang WQ
Acta Pharmacol Sin; 2018 Feb; 39(2):261-274. PubMed ID: 29388568
[TBL] [Abstract][Full Text] [Related]
6. Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cells.
Wang Q; Yen YT; Xie C; Liu F; Liu Q; Wei J; Yu L; Wang L; Meng F; Li R; Liu B
Drug Deliv; 2021 Dec; 28(1):510-519. PubMed ID: 33657950
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor aptamer-conjugated polymer-lipid hybrid nanoparticles enhance salinomycin delivery to osteosarcoma and cancer stem cells.
Yu Z; Chen F; Qi X; Dong Y; Zhang Y; Ge Z; Cai G; Zhang X
Exp Ther Med; 2018 Feb; 15(2):1247-1256. PubMed ID: 29399118
[TBL] [Abstract][Full Text] [Related]
8. Effects of D-α-tocopherol polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles on the absorption, pharmacokinetics, and pharmacodynamics of salinomycin sodium.
Li J; Zhai L; Xue J; Zhang H; Xie F; Gao J
Anticancer Drugs; 2019 Jan; 30(1):72-80. PubMed ID: 30239423
[TBL] [Abstract][Full Text] [Related]
9. Polymer-lipid hybrid anti-HER2 nanoparticles for targeted salinomycin delivery to HER2-positive breast cancer stem cells and cancer cells.
Li J; Xu W; Yuan X; Chen H; Song H; Wang B; Han J
Int J Nanomedicine; 2017; 12():6909-6921. PubMed ID: 29075110
[TBL] [Abstract][Full Text] [Related]
10. Gefitinib-loaded DSPE-PEG2000 nanomicelles with CD133 aptamers target lung cancer stem cells.
Huang X; Huang J; Leng D; Yang S; Yao Q; Sun J; Hu J
World J Surg Oncol; 2017 Aug; 15(1):167. PubMed ID: 28854941
[TBL] [Abstract][Full Text] [Related]
11. Promoted delivery of salinomycin sodium to lung cancer cells by dual targeting PLGA hybrid nanoparticles.
Zhou J; Sun J; Chen H; Peng Q
Int J Oncol; 2018 Sep; 53(3):1289-1300. PubMed ID: 30015824
[TBL] [Abstract][Full Text] [Related]
12. [Targeted killing of CD133
Pang L; Huang X; Zhu L; Xiao H; Li M; Guan H; Gao J; Jin H
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jan; 42(1):26-35. PubMed ID: 35249867
[TBL] [Abstract][Full Text] [Related]
13. Development of CD133 Targeting Multi-Drug Polymer Micellar Nanoparticles for Glioblastoma - In Vitro Evaluation in Glioblastoma Stem Cells.
Smiley SB; Yun Y; Ayyagari P; Shannon HE; Pollok KE; Vannier MW; Das SK; Veronesi MC
Pharm Res; 2021 Jun; 38(6):1067-1079. PubMed ID: 34100216
[TBL] [Abstract][Full Text] [Related]
14. Vitamin E-based redox-sensitive salinomycin prodrug-nanosystem with paclitaxel loaded for cancer targeted and combined chemotherapy.
Liang DS; Liu J; Peng TX; Peng H; Guo F; Zhong HJ
Colloids Surf B Biointerfaces; 2018 Dec; 172():506-516. PubMed ID: 30212688
[TBL] [Abstract][Full Text] [Related]
15. Promoted Delivery of Salinomycin to Lung Cancer Through Epidermal Growth Factor Receptor Aptamers Coupled DSPE-PEG2000 Nanomicelles.
Leng D; Hu J; Huang X; He W; Wang Y; Liu M
J Nanosci Nanotechnol; 2018 Aug; 18(8):5242-5251. PubMed ID: 29458573
[TBL] [Abstract][Full Text] [Related]
16. Salinomycin-loaded PLA nanoparticles: drug quantification by GPC and wave voltammetry and biological studies on osteosarcoma cancer stem cells.
Mineo PG; Foti C; Vento F; Montesi M; Panseri S; Piperno A; Scala A
Anal Bioanal Chem; 2020 Jul; 412(19):4681-4690. PubMed ID: 32451642
[TBL] [Abstract][Full Text] [Related]
17. Polylactic acid based biodegradable hybrid block copolymeric nanoparticle mediated co-delivery of salinomycin and doxorubicin for cancer therapy.
Anees M; Mehrotra N; Tiwari S; Kumar D; Kharbanda S; Singh H
Int J Pharm; 2023 Mar; 635():122779. PubMed ID: 36842520
[TBL] [Abstract][Full Text] [Related]
18. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells.
Zhou J; Sun M; Jin S; Fan L; Zhu W; Sui X; Cao L; Yang C; Han C
Drug Deliv; 2019 Dec; 26(1):281-289. PubMed ID: 30880491
[TBL] [Abstract][Full Text] [Related]
19. Development and Evaluation of Multifunctional Poly(Lactic-co-glycolic acid) Nanoparticles Embedded in Carboxymethyl β-Glucan Porous Microcapsules as a Novel Drug Delivery System for Gefitinib.
Li X; Wang J; Li S; Liu Z; Zheng Z; Zhang Y
Pharmaceutics; 2019 Sep; 11(9):. PubMed ID: 31547272
[TBL] [Abstract][Full Text] [Related]
20. Targeted salinomycin delivery with EGFR and CD133 aptamers based dual-ligand lipid-polymer nanoparticles to both osteosarcoma cells and cancer stem cells.
Chen F; Zeng Y; Qi X; Chen Y; Ge Z; Jiang Z; Zhang X; Dong Y; Chen H; Yu Z
Nanomedicine; 2018 Oct; 14(7):2115-2127. PubMed ID: 29898423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
